Neurostabilizers for migraine prevention. From dosage administration to patient expectations.
Wright
Wendy
W
Merrimack Village Family Practice, Merrimack, NH, USA.
D004305:Dose-Response Relationship, Drug; D005632:Fructose / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D018682:GABA Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008881:Migraine Disorders / Q000517:prevention & control*; D018696:Neuroprotective Agents / Q000009:adverse effects / Q000627:therapeutic use; D000077236:Topiramate; D014635:Valproic Acid / Q000009:adverse effects / Q000627:therapeutic use*
D018682:GABA Agents; D018696:Neuroprotective Agents; D000077236:Topiramate; D005632:Fructose; D014635:Valproic Acid